Intermittent Claudication
Open Access
- 1 September 1987
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 34 (3) , 404-410
- https://doi.org/10.2165/00003495-198734030-00006
Abstract
The mainstay of treatment for claudication is reversal of risk factors, especially smoking, and the use of antiplatelet drugs and possibly pentoxifylline. A major factor in the long term management...Keywords
This publication has 29 references indexed in Scilit:
- Fate in intermittent claudication: outcome and risk factors.BMJ, 1986
- INTERMITTENT CLAUDICATION: A DOUBLE-BLIND CROSSOVER TRIAL OF PENTOXIFYLLINEAustralian and New Zealand Journal of Medicine, 1985
- Pentoxifylline: A New Drug for the Treatment of Intermittent Claudication; Mechanism of Action, Pharmacokinetics, Clinical Efficacy and Adverse EffectsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984
- PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF KETANSERIN IN TREATMENT OF INTERMITTENT CLAUDICATIONThe Lancet, 1984
- FAILURE OF AUTOGENOUS REVERSED SAPHENOUS-VEIN FEMORO-POPLITEAL GRAFTING - PATHO-PHYSIOLOGY AND PREVENTION1982
- Effect of β-Blocking Drugs on Peripheral Blood Flow in Intermittent ClaudicationJournal of Cardiovascular Pharmacology, 1982
- Comparison of Above-Knee and Below-Knee Anastomosis in Femoropopliteal Bypass GraftsArchives of Surgery, 1981
- DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRINThe Lancet, 1979
- Intermittent claudication: its natural course.1975
- Results of Ankle Systolic Pressure Measurements in Patients With Intermittent Claudication Being Treated With ClofibrateAnnals of Surgery, 1975